Eszopiclone (Lunesta)

Indications

  • Insomnia (see Insomnia, [[Insomnia]])
  • To Increase Continuous Positive Airway Pressure (CPAP) Compliance in the Treatment of Obstructive Sleep Apnea (OSA) (see Obstructive Sleep Apnea, [[Obstructive Sleep Apnea]])
    • Short Course of Eszopiclone During the First 2 Weeks of CPAP Therapy Improves Adherence and Results in Fewer Patients Discontinuing CPAP Therapy [MEDLINE]

Pharmacology

  • xxx

Metabolism

  • xxxx

Administration

  • PO

Dose Adjustment

  • Hepatic:
  • Renal:

Adverse Effects

Other Adverse Effects

  • xxx
  • xxx
  • xxx

References

  • Effects of a short course of eszopiclone on continuous positive airway pressure adherence: a randomized trial. Ann Intern Med. 2009 Nov 17;151(10):696-702. doi: 10.7326/0003-4819-151-10-200911170-00006 [MEDLINE]